Skip to main content
Clinical Trials/NCT01377896
NCT01377896
Completed
Not Applicable

The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

AstraZeneca0 sites221 target enrollmentJuly 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
AstraZeneca
Enrollment
221
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

'Real life' retrospective patient cases (10) to provide an objective and robust analytical report of patient management and prescriptions behaviours for Schizophrenia, Bipolar disorders and Major depressive disorders.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
October 2010
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with one of the following conditions: Schizophrenia, Bipolar disorders and Major depressive disorders.

Exclusion Criteria

  • Patients who have not been diagnosed with the conditions as outlined in the Inclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials